Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Chronic Kidney Disease Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Kidney Disease Drugsmarket, defines the market attractiveness level of Chronic Kidney Disease Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chronic Kidney Disease Drugs industry, describes the types of Chronic Kidney Disease Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Kidney Disease Drugs market and the development prospects and opportunities of Chronic Kidney Disease Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Kidney Disease Drugs market in Chapter 13.
By Player:
AbbVie Inc
AstraZeneca
Amgen Inc
GlaxoSmithKline Plc
F Hoffmann-La Roche Ltd
By Type:
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
By End-User:
Hospitals
Specialty Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chronic Kidney Disease Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chronic Kidney Disease Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chronic Kidney Disease Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chronic Kidney Disease Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chronic Kidney Disease Drugs Market Analysis and Outlook to 2022
-
7.1 Global Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.2 United States Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.3 Europe Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.4 China Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.5 Japan Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.6 India Chronic Kidney Disease Drugs Consumption (2017-2022)
-
7.7 South Korea Chronic Kidney Disease Drugs Consumption (2017-2022)
8 Region and Country-wise Chronic Kidney Disease Drugs Market Analysis and Outlook to 2028
-
8.1 Global Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.2 United States Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.4 China Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.6 India Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Chronic Kidney Disease Drugs Consumption Forecast (2022-2028)
9 Global Chronic Kidney Disease Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Chronic Kidney Disease Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global ACE Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Chronic Kidney Disease Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Specialty Clinics Consumption and Growth Rate (2017-2022)
10 Global Chronic Kidney Disease Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global ACE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Chronic Kidney Disease Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chronic Kidney Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chronic Kidney Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chronic Kidney Disease Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chronic Kidney Disease Drugs Market Competitive Analysis
-
14.1 AbbVie Inc
-
14.1.1 AbbVie Inc Company Details
-
14.1.2 AbbVie Inc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Inc Chronic Kidney Disease Drugs Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Chronic Kidney Disease Drugs Product and Service
-
14.3 Amgen Inc
-
14.3.1 Amgen Inc Company Details
-
14.3.2 Amgen Inc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amgen Inc Chronic Kidney Disease Drugs Product and Service
-
14.4 GlaxoSmithKline Plc
-
14.4.1 GlaxoSmithKline Plc Company Details
-
14.4.2 GlaxoSmithKline Plc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Plc Chronic Kidney Disease Drugs Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chronic Kidney Disease Drugs
-
Figure Chronic Kidney Disease Drugs Picture
-
Table Global Chronic Kidney Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Kidney Disease Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chronic Kidney Disease Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chronic Kidney Disease Drugs Consumption by Country (2017-2022)
-
Figure United States Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chronic Kidney Disease Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Disease Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chronic Kidney Disease Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ACE Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global ACE Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chronic Kidney Disease Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chronic Kidney Disease Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie Inc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Chronic Kidney Disease Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Chronic Kidney Disease Drugs Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Chronic Kidney Disease Drugs Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Chronic Kidney Disease Drugs Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product and Service
-
